Status:
COMPLETED
Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures
Lead Sponsor:
UCB Pharma
Conditions:
Epilepsy
Eligibility:
All Genders
12-75 years
Phase:
PHASE3
Brief Summary
To provide continued treatment of Keppra XR (Levetiracetam XR) and to assess the long term safety of Keppra XR in subjects with partial onset seizures.
Eligibility Criteria
Inclusion
- Subjects who were randomized into study N01280 \[NCT00419094\], and completed the 2 week up titration period
Exclusion
- Subjects who did not meet the inclusion/exclusion criteria for N01280 \[NCT00419094\]
- Subjects who were discontinued prior to the end of titration period
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT00419393
Start Date
December 1 2007
End Date
March 1 2010
Last Update
September 5 2014
Active Locations (35)
Enter a location and click search to find clinical trials sorted by distance.
1
Dothan, Alabama, United States
2
Northport, Alabama, United States
3
Phoenix, Arizona, United States
4
Little Rock, Arkansas, United States